Rapid Degeneration of Cultured Human Brain Pericytes by Amyloid β Protein
暂无分享,去创建一个
[1] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Wiśniewski,et al. Non‐Fibrillar β‐Amyloid Protein is Associated with Smooth Muscle Cells of Vessel Walls in Alzheimer Disease , 1994, Journal of neuropathology and experimental neurology.
[3] D. Walsh,et al. Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide , 1993, Neuroscience Letters.
[4] G. Perry,et al. Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease , 1993, Brain Research.
[5] Carl W. Cotman,et al. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[6] T. Wisniewski,et al. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. , 1991, Biochemical and biophysical research communications.
[7] R. Gutiérrez,et al. Microvascular pericytes: a review of their morphological and functional characteristics. , 1991, Histology and histopathology.
[8] D. Kirschner,et al. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.
[9] F. Tagliavini,et al. Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[10] I. Lieberburg,et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.
[11] Carl W. Cotman,et al. Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.
[12] G. Bots,et al. Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy , 1988, Journal of the Neurological Sciences.
[13] B. Greenberg,et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors , 1988, Nature.
[14] C. Filley. Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.
[15] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[16] Z. Khachaturian. Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.
[17] G. Glenner,et al. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.
[18] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[19] T. Mandybur. The incidence of cerebral amyloid angiopathy in Alzheimer's disease , 1975, Neurology.
[20] J. Davisand. Enhancedpathologic properties ofDutch-type mutant amyloid 3-protein , 1996 .
[21] C. Cotman,et al. Amyloid βprotein precursor in cultured leptomeningeal smooth muscle cells , 1994 .
[22] D. Selkoe,et al. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. , 1992, The American journal of pathology.
[23] G. Glenner,et al. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. , 1981, Annales de pathologie.